Intel’s January: A Process, and a Sigh of Relief

Intel’s been a bit like a family member struggling with a mid-life crisis. A lot of grand pronouncements, some questionable purchases, and a general air of being slightly behind the curve. Pat Gelsinger, the former CEO, laid out this ambitious “five nodes in four years” plan. Sounded good on paper. My father had a similar plan for his vegetable garden, involving heirloom tomatoes and a complex irrigation system. It lasted approximately three weeks. But Intel, surprisingly, started to deliver. The Panther Lake CPU, built on this 18A node, was the first real test. A lot was riding on it, more than just stock prices. It was a matter of pride, really. A sort of “we used to be good at this” statement.

Arrowhead’s Ascent & Privium’s Prudence

Privium, it seems, reduced its stake in Arrowhead during the final quarter. However, and this is the amusing bit, the overall value of their remaining holding actually increased by a rather startling $10.09 million. A delightful paradox, wouldn’t you agree? The market, it appears, has been rather enthusiastic about Arrowhead’s prospects. One suspects a good deal of champagne flowed in certain boardrooms.

Silicon & Shadows

They make memory, these folks. Not the kind that clings to a man’s heart, but the silicon kind, the flash memory that holds the ghosts of our data. A few years back, the market was flooded, prices fell, and the margins withered. It was a hard time for everyone. Then came the hunger for more—a hunger born not of need, but of this new god, Artificial Intelligence. These AI ‘data centers,’ they require vast storehouses of memory, mountains of it, to feed their insatiable appetite.

Bonds & Bewilderment: A Portfolio’s Predicament

VCIT, the more…spirited of the two, focuses on corporate bonds of intermediate maturity. A calculated risk, you might say. BND, in contrast, casts a wider net, encompassing the entirety of the U.S. taxable bond market. It’s the difference between a specialist and a general practitioner. One promises a swift, precise cure; the other, a comprehensive, if somewhat slower, approach. The truly astute investor, naturally, understands that neither is a panacea, and that the devil, as always, resides in the details.

The Movie Scene Jack Nicholson Got Completely Stoned for and Why It Became Iconic

Let me tell you, shooting this film was…a trip. The cinematographer, László Kovács, later confessed there was a lot of drug use happening on set – it wasn’t a secret at all, apparently. Peter Fonda, who was both the star and a producer, backed that up, saying pretty much everyone involved had their preferred substance. For Fonda and director Dennis Hopper, that usually meant alcohol, though Fonda admitted he’d dabble in other things from time to time. It definitely sounds like a wild environment to be working in!

Why Quentin Tarantino Refuses To Make a Superhero Movie

In his book, Cinema Speculation, the director expressed his eagerness for a shift away from superhero movies dominating theaters. He shares Martin Scorsese’s view that these big-budget films feel more like theme park attractions than genuine cinema. Scorsese believes that true movies should center on people connecting through shared emotions and inner lives, instead of simply relying on large-scale spectacle.

Lemonade & the Illusion of Growth

The fund’s stake now totals two hundred and forty-eight thousand, two hundred and fifty-nine shares, valued at seventeen million, six hundred and seventy thousand dollars. An increase of nearly ten million from the previous quarter. One imagines the portfolio managers, seated in their quiet offices, charting these ascensions and descents. It’s a game of inches, really. A slow, relentless accumulation, or a quiet, unnoticed erosion.

Netflix, Warner, and the Inevitable

The shareholders are leaning toward Netflix, which is… predictable. People usually want more money. But there’s a hitch. A big, regulatory hitch. It’s never as simple as just handing over the keys, is it?

Bitcoin’s Bounce: A Mirage in the Desert of Resistance?

Bitcoin’s daily chart reveals a market still in the throes of recovery after a most ignominious descent from the lofty heights of $97,900, only to find itself at the nadir of $74,532. The subsequent rebound, though, was not a triumph of Olympian proportions, but rather a timid shuffle upwards.